Genomic Classifiers in Diagnosing Interstitial Lung Disease: Finding the Right Place at the Right Time
- PMID: 35648084
- PMCID: PMC9169131
- DOI: 10.1513/AnnalsATS.202112-1353ED
Genomic Classifiers in Diagnosing Interstitial Lung Disease: Finding the Right Place at the Right Time
Comment on
-
The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.Ann Am Thorac Soc. 2022 Jun;19(6):916-924. doi: 10.1513/AnnalsATS.202107-897OC. Ann Am Thorac Soc. 2022. PMID: 34889723 Clinical Trial.
References
-
- Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society Diagnosis of idiopathic pulmonary fibrosis: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med . 2018;198:e44–e68. - PubMed
-
- Lancaster L, Bonella F, Inoue Y, Cottin V, Siddall J, Small M, et al. Idiopathic pulmonary fibrosis: physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden Respirology [online ahead of print] 5 Oct 202110.1111/resp.14154 - DOI - PMC - PubMed
-
- Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med . 2018;6:138–153. - PubMed
-
- Aussedat PH, Chebib N, Ahmad K, Glerant JC, Drevet G, Grima R, et al. Impact of lung biopsy on lung function in idiopathic pulmonary fibrosis. Respiration . 2020;99:1101–1108. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
